Pokrovsky SN - Search Results

1

Low-density lipoprotein apheresis and regression of atherosclerotic plaque in vitro.

Orekhov AN, Khashimov KA, Mukhin DN, Tertov VV, Adamova IYu, Pokrovsky SN, Smirnov VN. Orekhov AN, et al. Among authors: pokrovsky sn. Artif Organs. 1986 Dec;10(6):466-9. doi: 10.1111/j.1525-1594.1986.tb02605.x. Artif Organs. 1986. PMID: 3800702

2

Immunosorbent for selective removal of lipoprotein (a) from human plasma: in vitro study.

Pokrovsky SN, Adamova IYu, Afanasieva OY, Benevolenskaya GF. Pokrovsky SN, et al. Artif Organs. 1991 Apr;15(2):136-40. doi: 10.1111/j.1525-1594.1991.tb00771.x. Artif Organs. 1991. PMID: 1827976

3

Autoantibodies against modified low density lipoprotein. Nonlipid factor of blood plasma that stimulates foam cell formation.

Orekhov AN, Tertov VV, Kabakov AE, Adamova IYu, Pokrovsky SN, Smirnov VN. Orekhov AN, et al. Among authors: pokrovsky sn. Arterioscler Thromb. 1991 Mar-Apr;11(2):316-26. doi: 10.1161/01.atv.11.2.316. Arterioscler Thromb. 1991. PMID: 1998649

4

Immunosorbents for LDL-apheresis.

Pokrovsky SN, Adamova IYu, Benevolenskaya GF. Pokrovsky SN, et al. Biomater Artif Cells Artif Organs. 1990;18(5):623-8. doi: 10.3109/10731199009117330. Biomater Artif Cells Artif Organs. 1990. PMID: 2099217

5

LDL apheresis and regression of atherosclerosis.

Tertov VV, Khashimov KhA, Orekhov AN, Mukhin DN, Kurdanov KhA, Chichinadze OM, Pokrovsky SN. Tertov VV, et al. Among authors: pokrovsky sn. Lancet. 1985 May 11;1(8437):1108-9. doi: 10.1016/s0140-6736(85)92415-8. Lancet. 1985. PMID: 2860324 No abstract available.

6

Blood serum atherogenicity associated with coronary atherosclerosis. Evidence for nonlipid factor providing atherogenicity of low-density lipoproteins and an approach to its elimination.

Orekhov AN, Tertov VV, Pokrovsky SN, Adamova IYu, Martsenyuk ON, Lyakishev AA, Smirnov VN. Orekhov AN, et al. Among authors: pokrovsky sn. Circ Res. 1988 Mar;62(3):421-9. doi: 10.1161/01.res.62.3.421. Circ Res. 1988. PMID: 3342473

7

Artificial HDL as an anti-atherosclerotic drug.

Orekhov AN, Misharin AYu, Tertov VV, Khashimov KhA, Pokrovsky SN, Repin VS, Smirnov VN. Orekhov AN, et al. Among authors: pokrovsky sn. Lancet. 1984 Nov 17;2(8412):1149-50. doi: 10.1016/s0140-6736(84)91574-5. Lancet. 1984. PMID: 6150198 No abstract available.

8

Development of immunosorbents for apoB-containing lipoproteins apheresis.

Pokrovsky SN, Sussekov AV, Adamova IY, Afanasieva OI, Benevolenskaya GF, Konovalov GA, Kukharchuk VV. Pokrovsky SN, et al. Artif Organs. 1995 Jun;19(6):500-5. doi: 10.1111/j.1525-1594.1995.tb02369.x. Artif Organs. 1995. PMID: 8526788 Clinical Trial.

9

Lipoprotein(a) apheresis.

Pokrovsky SN, Afanasieva OI, Ezhov MV. Pokrovsky SN, et al. Curr Opin Lipidol. 2016 Aug;27(4):351-8. doi: 10.1097/MOL.0000000000000319. Curr Opin Lipidol. 2016. PMID: 27213629 Review.

10

Immunosorbent for IgG apheresis: an in vitro study.

Kiseleva EA, Afanasieva OI, Kosheleva NA, Pokrovsky SN. Kiseleva EA, et al. Among authors: pokrovsky sn. Transfus Sci. 1996 Dec;17(4):519-25. Transfus Sci. 1996. PMID: 10168549

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

49 results

Search Page